<!DOCTYPE html>
<html lang="en-us">
  <head>
	<meta name="generator" content="Hugo 0.85.0" />
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    
    <title>fallingstar-Daily-rss | Fallingstar Daily R</title>
    <link rel="stylesheet" href="/css/style.css" />
    <link rel="stylesheet" href="/css/fonts.css" />
    <link href="//cdn.bootcss.com/highlight.js/9.12.0/styles/github.min.css" rel="stylesheet">

  </head>

  <body>
    <nav class="header">
      <div class="banner">
<a href="/" class="text">
&Ffr;&Afr;&Lfr;&Lfr;&Ifr;&Nfr;&Gfr;&Sfr;&Tfr;&Afr;&Rfr; &Dfr;&Afr;&Ifr;&Lfr;&Yfr; &Rfr;
</a>
</div>

      <div class="head-meta">
      
        <span>fallingstar-Daily-rss</span>
        <span>2024-05-23</span>
      
      </div>
    </nav>


<div class="container">
<main class="list">

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38778718/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240523183437&amp;v=2.18.0.post9&#43;e462414">Associations between tobacco smoking status and patch test results-A cross-sectional pilot study from the Information Network of Departments of Dermatology (IVDK)</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38778718-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240523183437-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Although our study does not allow a firm conclusion on whether smoking status contributes to certain contact sensitizations, it confirms an association of smoking with hand dermatitis and occupational &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38778793/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240523183437&amp;v=2.18.0.post9&#43;e462414">Early Access to First-Seizure Clinics, Subsequent Outcomes, and Factors Associated With Attendance</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38778793-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240523183437-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS AND RELEVANCE: Results of this cohort study suggest that FSC attendance, particularly early attendance, was associated with reduced rates of subsequent hospital utilization. This knowledge may support adequately resourcing FSCs to improve equitable, timely access. Future study directions include assessing interventions that may support FSC attendance for at-risk &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38779395/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240523183437&amp;v=2.18.0.post9&#43;e462414">Evaluation of Different Patterns of Zygomaticoorbital Complex Fractures</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38779395-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240523183437-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: According to the results, knowledge of the fracture pattern variability of the ZMO complex could in certain circumstances designate CT or CBCT as mandatory before operating on ZMO fractures. Consequently, unnecessary incisions could be avoided. The high concomitance of paranasal buttress fracture also suggests its intraoperative surgical exploration. Further studies should correlate the clinical findings with indication for surgery and postoperative outcome for the &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38779691/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240523183437&amp;v=2.18.0.post9&#43;e462414">A case of severe side effects to androgen receptor inhibitor and consequently switch to radioligand therapy in early castration resistant prostate cancer</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38779691-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240523183437-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The development of potent novel androgen receptor inhibitors (ARi) such as apalutamide have improved the life expectancy in men with castration-resistant prostate cancer (CRPCa). However, some serious toxicity can occur limiting the choice of treatment in CRPCa. In our case, the patient experienced severe toxicity after initiation of apalutamide. Diagnostic PSMA-PET/CT confirmed the recurrence and tailored the treatment with ^(177)Lu-PSMA-617 (RLT), a beta emitter radionuclide. RLT resulted &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38779695/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240523183437&amp;v=2.18.0.post9&#43;e462414">What do the teachers want? A targeted needs assessment survey for prospective didactic training of psychiatry medical educators</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38779695-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240523183437-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: The majority of physicians and psychologists at psychiatric university hospitals considered professional development for faculty to be helpful for teaching medical students. Bedside teaching and error culture management were the most desired teaching topics for training medical teachers. Tailored educational interventions are recommended, with target-oriented priorities for different hierarchical &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38779910/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240523183437&amp;v=2.18.0.post9&#43;e462414">PCM4EU and PRIME-ROSE: Collaboration for implementation of precision cancer medicine in Europe</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38779910-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240523183437-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: European collaboration can facilitate the implementation of PCM and thereby provide affordable and equitable access to precision diagnostics and matched therapies for more patients. ble from the PCM4EU website (<a href="http://www.pcm4eu.eu">http://www.pcm4eu.eu</a>). The first reports, including an overview of requirements for the reimbursement systems in participating countries and a guide on patient involvement, are expected to be published in &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38780378/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1LIK-026Y9bjRE4xDQ231BSa89BnY4O2Rfi-9WXQd8C31C6cqE&amp;fc=20211015124055&amp;ff=20240523183433&amp;v=2.18.0.post9&#43;e462414">Audio Interview: Preparing for a PossibleÂ Avian Influenza Outbreak</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38780378-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1lik-026y9bjre4xdq231bsa89bny4o2rfi-9wxqd8c31c6cqe-fc-20211015124055-ff-20240523183433-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38780548/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240523183437&amp;v=2.18.0.post9&#43;e462414">State and trait characteristics of attachment as predictors of outcome in inpatient psychotherapy</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38780548-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240523183437-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Attachment has mostly been investigated as a stable characteristic of individuals, although theoretical considerations and recent empirical findings suggest that attachment styles are also subject to change. When attachment is investigated as a treatment factor in psychotherapy, state and trait characteristics need to be differentiated, as they warrant different conclusions. This study examined the trait- and statelike characteristics of attachment styles over the course of &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38780712/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240523183437&amp;v=2.18.0.post9&#43;e462414">Prognostic relevance of global work index and global constructive work in patients with non-ischemic dilated cardiomyopathy</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38780712-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240523183437-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Myocardial work (MW) derived from pressure-strain loops is a novel non-invasive tool to assess left ventricular (LV) function, incorporating global longitudinal strain (GLS) by speckle tracking echocardiography and non-invasively assessed blood pressure. Studies on the role of MW in dilated cardiomyopathy (DCM) are still limited. Therefore, the aim of this study was to evaluate the potential value of MW for predicting adverse outcomes in patients with DCM. 116 consecutive patients with DCM &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38780804/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240523183437&amp;v=2.18.0.post9&#43;e462414">MAGnetic REtriaval device for minimally invasive Ureter Stent removal (MAGREUS)</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38780804-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240523183437-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Purpose To assess the effectiveness and pain intensity associated with magnetic ureteric stent removal using a retriever, without the aid of ultrasound guidance. Methods We prospectively enrolled 100 patients who underwent retrograde rigid/flexible ureterorenoscopy with or without laser lithotripsy for ureteronephrolithiasis treatment from September 2021 to June 2023. These patients were assigned in two groups. Group 1 underwent the traditional ureteric stent insertion, while Group 2 &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38780812/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240523183437&amp;v=2.18.0.post9&#43;e462414">Correction: Commentary of the SKLM to the EFSA opinion on risk assessment of N-nitrosamines in food</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38780812-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240523183437-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38780837/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240523183437&amp;v=2.18.0.post9&#43;e462414">Prevention at home in older persons with (pre-)frailty: analysis of participants&#39; recruitment and characteristics of the randomized controlled PromeTheus trial</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38780837-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240523183437-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: Different strategies may be required to successfully recruit (pre-)frail home-living older adults into preventive programs. Direct recruitment strategies, in which potential participants are directly informed about the prevention program, seem to be more promising than GP recruitment but may result in enrolment of persons with less functional impairment and higher recruitment &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38780917/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240523183435&amp;v=2.18.0.post9&#43;e462414">SMACing down relapsed T-ALL</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38780917-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240523183435-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38780918/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240523183435&amp;v=2.18.0.post9&#43;e462414">VEXAS syndrome: from a vascular perspective</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38780918-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240523183435-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38780919/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240523183435&amp;v=2.18.0.post9&#43;e462414">The stepbrothers of ABLSON have their own sensitivity</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38780919-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240523183435-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38780920/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240523183435&amp;v=2.18.0.post9&#43;e462414">Oxygen tug-of-war, voxelotor, and the brain</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38780920-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240523183435-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38780921/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240523183435&amp;v=2.18.0.post9&#43;e462414">&#34;Ring-form&#34; megakaryocytic dysplasia in STAG2-mutated myelodysplastic neoplasm</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38780921-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240523183435-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38780922/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240523183435&amp;v=2.18.0.post9&#43;e462414">Giving T-cell bispecifics a helping hand</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38780922-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240523183435-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38780923/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240523183435&amp;v=2.18.0.post9&#43;e462414">Conditioning for alloengraftment in FA</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38780923-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240523183435-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38780924/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240523183435&amp;v=2.18.0.post9&#43;e462414">Biclonal mantle cell lymphoma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38780924-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240523183435-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OfFBG0EL3">ð»æä¸ªå¾ç®åçéçï¼ä½æ¯ä¹å¯ä»¥è®²ä¸ä¸ï¼ð»ä¸ççè¿è¡æ¯å®¢è§çï¼äºç©çåå±æ¯å®¢è§çï¼äºä¸çåè¿ä¹æ¯å®¢è§çï¼å¯¹äºäºä¸çææï¼å¹¶ä¸æ¯ææäººé½è½çè§£ï¼ä»ä¸­å½...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-offbg0el3/">
    
    
    
    
    
      
    
    ð»æä¸ªå¾ç®åçéçï¼ä½æ¯ä¹å¯ä»¥è®²ä¸ä¸ï¼<!-- raw HTML omitted -->ð»ä¸ççè¿è¡æ¯å®¢è§çï¼äºç©çåå±æ¯å®¢è§çï¼äºä¸çåè¿ä¹æ¯å®¢è§çï¼å¯¹äºäºä¸çææï¼å¹¶ä¸æ¯ææäººé½è½çè§£ï¼ä»ä¸­å½é©å½çä¸å¼å§ï¼âè¿ä¹åæä»ä¹ç¨âççé®å°±ä¸ç´å­å¨ã<!-- raw HTML omitted -->ð»æååå¿æ¾ç»è¯´ï¼âä¸­å½è¿ä¸ªå®¢è§ä¸çï¼æ´ä¸ªå°è¯´æ¥ï¼æ¯ç±ä¸­å½äººè®¤è¯çï¼ä¸æ¯å¨å±äº§å½éç®¡ä¸­å½é®é¢çåå¿ä»¬è®¤è¯çãå±äº§å½éçè¿äºåå¿å°±ä¸äºè§£æèè¯´ä¸å¾äºè§£ä¸­å½ç¤¾ä¼ï¼ä¸­ å½ æ° æï¼ä¸­ å½ é© å½ãå¯¹äºä¸­å½è¿ä¸ªå®¢è§ä¸çï¼æä»¬èªå·±å¨å¾é¿æ¶é´åé½è®¤è¯ä¸æ¸æ¥ï¼ä½åµå¤å½åå¿å¢ï¼â<!-- raw HTML omitted -->ð» æä»¬çå®è·µè¯æï¼æè§å°äºçä¸è¥¿ï¼æä»¬ä¸è½ç«å»çè§£å®ï¼åªæçè§£äºçä¸è¥¿ææ´æ·±å»å°æè§å®ãæè§åªè§£å³ç°è±¡é®é¢ï¼çè®ºæè§£å³æ¬è´¨é®é¢ãè¿ &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OfFI7AeGb">å¯¹[è£å¼]//@å³äºèèé²¨:å°±æ¯é£ä¸ªå·2000å¨é¢ç­çï¼ - è½¬å @åå®¹ä¸ç©ææ²³æ°´:&amp;ensp;ð»ç¬¬235å«æåºåäºæ³åº­ç§°ï¼è¾©æ¹å¯¹æ¶å«æ¬ºè¯çå58éå¢åå¸ä»¤ä¼ä¸Â·æ³¢æ³¢å¤«å°å°...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-offi7aegb/">
    
    
    
    
    
      
    
    å¯¹<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->//<!-- raw HTML omitted -->@å³äºèèé²¨<!-- raw HTML omitted -->:å°±æ¯é£ä¸ªå·2000å¨é¢ç­çï¼<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å <!-- raw HTML omitted -->@åå®¹ä¸ç©ææ²³æ°´<!-- raw HTML omitted -->:âð»ç¬¬235å«æåºåäºæ³åº­ç§°ï¼è¾©æ¹å¯¹æ¶å«æ¬ºè¯çå58éå¢åå¸ä»¤ä¼ä¸Â·æ³¢æ³¢å¤«å°å°çæçæåºä¸è¯ãæ­£å¦å¾å¸è°¢å°çÂ·å¸ä¼è¯ºå¤«æ¯åºåè¯å¡æ¯ç¤¾çé£æ ·ï¼ä»ä¸æ¿è®¤ç¯æä»»ä½éæ³è¡ä¸ºã<!-- raw HTML omitted -->ð»ç®åï¼ä¿ç½æ¯ä¾¦æ¥å§åä¼è¦æ±éæ¾è¢«æççæ³¢æ³¢å¤«å°åï¼ä»¥ç &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OfFJ8DfJu">ð»å®¶äººä»¬ï¼æä»å¤©çå°ä¸ä¸ªå¨è±ä¼è¾¾éå¤§è´¢æ¥åå¸ååç©ºçãð»å®åä¸åï¼ [å¾ç]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-offj8dfju/">
    
    
    
    
    
      
    
    ð»å®¶äººä»¬ï¼æä»å¤©çå°ä¸ä¸ªå¨è±ä¼è¾¾éå¤§è´¢æ¥åå¸ååç©ºçã<!-- raw HTML omitted -->ð»å®åä¸åï¼ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OfFJYof68">åæ­£ä»ç°å¨èçç½ªåæ¯ï¼âçåäº1700å¨ææ³¢ç½ç­ä½ä¸ºäººéä¸»ä¹ç©èµææ¥çéå±âã//@è¿ä¸ªåç§°å¥½lowå:ä»å·é£ä¹å¤é¢ç­è½¬æåäºï¼è¿æ¯å¹²å¥äº//@åå®¹ä¸ç©ææ²³æ°´:å¯¹[è£...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-offjyof68/">
    
    
    
    
    
      
    
    åæ­£ä»ç°å¨èçç½ªåæ¯ï¼âçåäº1700å¨ææ³¢ç½ç­ä½ä¸ºäººéä¸»ä¹ç©èµææ¥çéå±âã//<!-- raw HTML omitted -->@è¿ä¸ªåç§°å¥½lowå<!-- raw HTML omitted -->:ä»å·é£ä¹å¤é¢ç­è½¬æåäºï¼è¿æ¯å¹²å¥äº//<!-- raw HTML omitted -->@åå®¹ä¸ç©ææ²³æ°´<!-- raw HTML omitted -->:å¯¹<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->//&lt;a href=&ldquo;<a href="https://weibo.com/n/%E5%258">https://weibo.com/n/%E5%8</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OfFmWrpFD">ð»æ¼è°·å»é¢å®åè¯´ï¼å¨æ°å å¡èªç©ºå¬å¸æ¹æµèªç­ä¸ä»å¨æ¥åæ²»çç 40 äººä¸­ï¼22 äººèæ¤åä¼¤ï¼6 äººèé¨åé¢éª¨åä¼¤ãð»via Al Jazeera ç½ç«ð»â¦â¦ [å¾ç]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-offmwrpfd/">
    
    
    
    
    
      
    
    ð»æ¼è°·å»é¢å®åè¯´ï¼å¨æ°å å¡èªç©ºå¬å¸æ¹æµèªç­ä¸ä»å¨æ¥åæ²»çç 40 äººä¸­ï¼22 äººèæ¤åä¼¤ï¼6 äººèé¨åé¢éª¨åä¼¤ã<!-- raw HTML omitted -->ð»via Al Jazeera ç½ç«<!-- raw HTML omitted -->ð»â¦â¦ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OfFnxvk1V">ä½ è¿ä¸ªå°ä¸å®¤æ­£ç»åï¼ - è½¬å @åå®¹ä¸ç©ææ²³æ°´:&amp;ensp;ð»å¡å¾·ç½å¤«è¯´ï¼âææä¸ä¸ªæ¢¦æ³ââææ³½è¿æ¯åºå®ç½®å¨æä»¬è½¦è£çå°ä¸å®¤éãâð»via RTå®ç½ð»[åå¦Aæ¢¦å®³...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-offnxvk1v/">
    
    
    
    
    
      
    
    ä½ è¿ä¸ªå°ä¸å®¤æ­£ç»åï¼<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å <!-- raw HTML omitted -->@åå®¹ä¸ç©ææ²³æ°´<!-- raw HTML omitted -->:âð»å¡å¾·ç½å¤«è¯´ï¼âææä¸ä¸ªæ¢¦æ³ââææ³½è¿æ¯åºå®ç½®å¨æä»¬è½¦è£çå°ä¸å®¤éãâ<!-- raw HTML omitted -->ð»via RTå®ç½<!-- raw HTML omitted -->ð»<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ï¼ <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://h5.sinaimg.cn/upload/2015/09/25/3/timeline_card_small_video_default.png%22">https://h5.sinaimg.cn/upload/2015/09/25/3/timeline_card_small_video_default.png&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OfFoVxVaS">ð»ä¿åç¬¬ 27 å¸çç®åµç¨ D-30 æ¦´å¼¹ç®å½ä¸­äºä¸è¾ M1ãð»D-30 çç®å¼¹å¥½åå ç¾ç¾åä¸åï¼ð»via vk/RVV [å¾ç]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-offovxvas/">
    
    
    
    
    
      
    
    ð»ä¿åç¬¬ 27 å¸çç®åµç¨ D-30 æ¦´å¼¹ç®å½ä¸­äºä¸è¾ M1ã<!-- raw HTML omitted -->ð»D-30 çç®å¼¹å¥½åå ç¾ç¾åä¸åï¼<!-- raw HTML omitted -->ð»via vk/RVV <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;source src=&ldquo;<a href="https://f.video.weibocdn.com/o0/4brZXn6Llx08f5wpDcRy010412001cxh0E010.mp4?label=mp4_hd&amp;amp;template=848x464.25.0&amp;amp;ori=0&amp;amp;ps=1Cx9YB1mmR49jS&amp;amp;Expires=1716505909&amp;amp;ssig=XGZMBjsqJe&amp;am">https://f.video.weibocdn.com/o0/4brZXn6Llx08f5wpDcRy010412001cxh0E010.mp4?label=mp4_hd&amp;amp;template=848x464.25.0&amp;amp;ori=0&amp;amp;ps=1Cx9YB1mmR49jS&amp;amp;Expires=1716505909&amp;amp;ssig=XGZMBjsqJe&amp;am</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OfFqImzMd">ð»âç»ä¸å¥é¤âåæ¾ä¸è¾¹ãð»ç»è¯´ä¸ºä»ä¹å ç­ï¼#ä¸­å½å°æ¹¾937è°è¿éæ¯ä¸­å½ç®¡è¾æµ·å# [å¾ç]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-offqimzmd/">
    
    
    
    
    
      
    
    ð»âç»ä¸å¥é¤âåæ¾ä¸è¾¹ã<!-- raw HTML omitted -->ð»ç»è¯´ä¸ºä»ä¹å ç­ï¼<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->#ä¸­å½å°æ¹¾937è°è¿éæ¯ä¸­å½ç®¡è¾æµ·å#<!-- raw HTML omitted --><!-- raw HTML omitted --> &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax4.sinaimg.cn/large/639b1bfbly1hpzvt75svvj20hx0qtdsi.jpg%22">https://tvax4.sinaimg.cn/large/639b1bfbly1hpzvt75svvj20hx0qtdsi.jpg&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OfFr7sr2D">ð»ï¼ [å¾ç]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-offr7sr2d/">
    
    
    
    
    
      
    
    ð»ï¼ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OfFssbIIa">ð»æç¥éè¿ä¸ªè§é¢æ¯AIæ¢è¸ãð»ä½æ¯ï¼è¿ä¸ªè§é¢æµä¼ æå¶å¹¿ï¼ææçå¡å¾·ç½å¤«æ¯ä¸æ¯çäºè¿ä¸ªè§é¢æè¯´åºâæ³æä»å®ç½®å¨è½¦è£å°ä¸å®¤âè¿å¥è¯ï¼ [å¾ç]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-offssbiia/">
    
    
    
    
    
      
    
    ð»æç¥éè¿ä¸ªè§é¢æ¯AIæ¢è¸ã<!-- raw HTML omitted -->ð»ä½æ¯ï¼è¿ä¸ªè§é¢æµä¼ æå¶å¹¿ï¼ææçå¡å¾·ç½å¤«æ¯ä¸æ¯çäºè¿ä¸ªè§é¢æè¯´åºâæ³æä»å®ç½®å¨è½¦è£å°ä¸å®¤âè¿å¥è¯ï¼ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;source src=&ldquo;<a href="https://f.video.weibocdn.com/o0/D0Eumk1Glx08f5x0Fyly010412004QaV0E010.mp4?label=mp4_hd&amp;amp;template=360x638.24.0&amp;amp;ori=0&amp;amp;ps=1Cx9YB1mmR49jS&amp;amp;Expires=1716505909&amp;amp;ssi">https://f.video.weibocdn.com/o0/D0Eumk1Glx08f5x0Fyly010412004QaV0E010.mp4?label=mp4_hd&amp;amp;template=360x638.24.0&amp;amp;ori=0&amp;amp;ps=1Cx9YB1mmR49jS&amp;amp;Expires=1716505909&amp;amp;ssi</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OfCUK47GM">ä¹ä¿å²ç»ªé#ä¹ä¿å²ç»ªéææºå# 2024.05.19 13:34(è¡¥)ãåâ¦ãæ¨å¤©çæè£å¤ªå¯ç±å¦â¦æ¥ççâ¦ [å¾ç]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-ofcuk47gm/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹ä¿å²ç»ªé<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;span &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OfCZxrBDG">ä¹ä¿å²ç»ªé#ä¹ä¿å²ç»ªéææºå# 2024.05.19 13:34ãé¿ãå¤§å®¶å¥½æ©ä¸å¼å§å°±åå¤æ­æ¾ãMela!ããæ¨å¤©æ¯å¼å¿å¾å¼å¿å¾é¾ä»¥å¿è®°çæ¶åçè³ä¼æ³æ¯ä¸æ¯å¨åæ¢¦ãå¼å¼å¼ãä»...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-ofczxrbdg/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹ä¿å²ç»ªé<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%8D%259">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%8D%9</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OfD96Blzr">ä¹ä¿å²ç»ªé#ä¹ä¿å²ç»ªéææºå# 2024.05.20 10:38(è¡¥)ãå¦ï¼ãæ©ä¸å¥½ãä»å¤©ä¹ç»§ç»­åªåå§ä»å¤©å¢ï¼æ¯è¦å°æèçåç§ä¸è¥¿è®¤çç§¯æå°æ¨è¿çæ¥å­ãæ²¡æä»ä¹ç¹å«çææ...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-ofd96blzr/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹ä¿å²ç»ªé<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%8D%9A%23">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%8D%9A%23</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OfD9Jk20c">ä¹ä¿å²ç»ªé#ä¹ä¿å²ç»ªéææºå# 2024.05.22 12:43(è¡¥)ãæ­ãå¤§å®¶å¥½ä»å¤©ä¹é¼è¶³å¹²å²åªåå§æè¦åçäºå·²ç»å ç§¯å¦å±±äºåªåå§éä¸è§£å³å§å¥½å</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-ofd9jk20c/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹ä¿å²ç»ªé<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%8D%9A%23&amp;amp;isnewpage=1%22">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%8D%9A%23&amp;amp;isnewpage=1&quot;</a>  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OfD9x15b4">ä¹ä¿å²ç»ªé#ä¹ä¿å²ç»ªéææºå# 2024.05.20 17:48(è¡¥)ãè¦çå¦ãä»å¤©19ç¹å¼å§ï¼JSTï¼æ¯nogiobiå¦ï¼ï¼è¦çå¦ï¼æ¯nogiobiå¦ï¼ï¼ï¼ï¼ï¼è¦çå¦ï¼å ä¸ºæ¯éè¦çäºæä»¥è¯´...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-ofd9x15b4/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹ä¿å²ç»ªé<!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%8D%9A%23&amp;am">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%85%E4%BF%9D%E5%8F%B2%E7%BB%AA%E9%87%8C%E6%89%8B%E6%9C%BA%E5%8D%9A%23&amp;am</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OfE6QcIkE">ä¹ä¿å²ç»ªé - è½¬å @ä¹æ¨å46:&amp;ensp;ð¸#ä¹æ¨å46GALLERY#ð¸ðWorksðä¹æ¨å46 [å¾ç][å¾ç][å¾ç][å¾ç][å¾ç][å¾ç][å¾ç][å¾ç][å¾ç]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-ofe6qcike/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹ä¿å²ç»ªé<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å <!-- raw HTML omitted -->@ä¹æ¨å46<!-- raw HTML omitted -->:âð¸&lt;a href=&ldquo;<a href="https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%83%E6%9C%A8%E5%9D%8246GALLERY%252">https://m.weibo.cn/search?containerid=231522type%3D1%26t%3D10%26q%3D%23%E4%B9%83%E6%9C%A8%E5%9D%8246GALLERY%2</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.bilibili.com/video/BV1iH4y1u7fD">éç¿å­ç¹åï¼æ¿ä½ æä¸æ¸©æä¸æèé</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/www-bilibili-com-video-bv1ih4y1u7fd/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.npr.org/2024/05/23/1198908837/throughline-philippines">Mythos and Melodrama in the Philippines (Throwback)</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-23</span>
  </div>
  <div class="summary">
    <a href="/post/www-npr-org-2024-05-23-1198908837-throughline-philippines/">
    
    
    
    
    
      
    
    Welcome to the &ldquo;Epic of Marcos.&rdquo; In this tale of a family that&rsquo;s larger than life, Ferdinand Marcos, the former dictator of the Philippines, is at the center. But the figures that surround him are just as important: Imelda, his wife and muse; Bongbong, his heir; and the United States, his faithful sidekick. The story of the Marcos family is a blueprint for authoritarianism, laying out clearly how melodrama, paranoia, love, betrayal and a hunger for power collide to create a myth capable of propelling a nation. Today on the show, the rise, fall, and resurrection of a dynasty â and what that &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38773599/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240522182830&amp;v=2.18.0.post9&#43;e462414">Breakthroughs in choroid plexus and CSF biology from the first European Choroid plexus Scientific Forum (ECSF)</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-22</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38773599-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240522182830-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The European Choroid plexus Scientific Forum (ECSF), held in Heidelberg, Germany between the 7th and 9th of November 2023, involved 21 speakers from eight countries. ECSF focused on discussing cutting-edge fundamental and medical research related to the development and functions of the choroid plexus and its implications for health, aging, and disease, including choroid plexus tumors. In addition to new findings in this expanding field, innovative approaches, animal models and 3D in vitro &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38773619/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1x5bM_TNL8gjogAcnslpo2s2PbDe-61JVM2h9yowOYSiZ7Dkrt&amp;fc=20220919211934&amp;ff=20240522182120&amp;v=2.18.0.post9&#43;e462414">The biomedical knowledge graph of symptom phenotype in coronary artery plaque: machine learning-based analysis of real-world clinical data</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-22</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38773619-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1x5bm-tnl8gjogacnslpo2s2pbde-61jvm2h9yowoysiz7dkrt-fc-20220919211934-ff-20240522182120-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    A knowledge graph can effectively showcase the essential characteristics of data and is increasingly emerging as a significant means of integrating information in the field of artificial intelligence. Coronary artery plaque represents a significant etiology of cardiovascular events, posing a diagnostic challenge for clinicians who are confronted with a multitude of nonspecific symptoms. To visualize the hierarchical relationship network graph of the molecular mechanisms underlying &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38773619/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1x5bM_TNL8gjogAcnslpo2s2PbDe-61JVM2h9yowOYSiZ7Dkrt&amp;fc=20220919211934&amp;ff=20240523183359&amp;v=2.18.0.post9&#43;e462414">The biomedical knowledge graph of symptom phenotype in coronary artery plaque: machine learning-based analysis of real-world clinical data</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-22</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38773619-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1x5bm-tnl8gjogacnslpo2s2pbde-61jvm2h9yowoysiz7dkrt-fc-20220919211934-ff-20240523183359-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    A knowledge graph can effectively showcase the essential characteristics of data and is increasingly emerging as a significant means of integrating information in the field of artificial intelligence. Coronary artery plaque represents a significant etiology of cardiovascular events, posing a diagnostic challenge for clinicians who are confronted with a multitude of nonspecific symptoms. To visualize the hierarchical relationship network graph of the molecular mechanisms underlying &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38773643/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240522182830&amp;v=2.18.0.post9&#43;e462414">High-precision stereotactic irradiation for focal drug-resistant epilepsy versus standard treatment: a randomized waitlist-controlled trial (the PRECISION trial)</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-22</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38773643-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240522182830-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    INTRODUCTION: The standard treatment for patients with focal drug-resistant epilepsy (DRE) who are not eligible for open brain surgery is the continuation of anti-seizure medication (ASM) and neuromodulation. This treatment does not cure epilepsy but only decreases severity. The PRECISION trial offers a non-invasive, possibly curative intervention for these patients, which consist of a single stereotactic radiotherapy (SRT) treatment. Previous studies have shown promising results of SRT in &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38773750/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240522182830&amp;v=2.18.0.post9&#43;e462414">Psychedelic therapy in depression and substance use disorders</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-22</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38773750-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240522182830-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Psychoactive substances obtained from botanicals have been applied for a wide variety of purposes in the rituals of different cultures for thousands of years. Classical psychedelics from N,N'-dimethyltryptamine, psilocybin, mescaline and various lysergamides cause specific alterations in perception, emotion and cognition by acting through serotonin 5-HT(2A) receptor activation. Lysergic acid diethylamide, the first famous breakthrough in the field, was discovered by chance by Albert Hoffman &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38773813/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240522182830&amp;v=2.18.0.post9&#43;e462414">Severe acute liver disease in adults: Contemporary role of histopathology</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-22</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38773813-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240522182830-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Liver biopsies have consistently contributed to our understanding of the pathogenesis and aetiologies of acute liver disease. As other diagnostic modalities have been developed and refined, the role of biopsy in the management of patients with acute liver failure (ALF), acute-on-chronic liver failure (ACLF) and acute hepatitis, including acute liver injury (ALI), has changed. Liver biopsy remains particularly valuable when first-line diagnostic algorithms fail to determine aetiology. Despite &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38773844/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240522182830&amp;v=2.18.0.post9&#43;e462414">Increase of Cardiac Autoantibodies Against Beta-2-adrenergic Receptor During Acute Cellular Heart Transplant Rejection</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-22</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38773844-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240522182830-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: Our study served as a feasibility analysis for a peptide array screening approach in HTx recipients during ACR and identified 2 different regulated aABs in ACR-HTx. Hence, further multicenter studies are needed to evaluate the prognostic implications of aAB testing and diagnostic or therapeutic &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38773968/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240522182830&amp;v=2.18.0.post9&#43;e462414">Activation of the hypoxia-inducible factor pathway protects against acute ischemic stroke by reprogramming central carbon metabolism</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-22</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38773968-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240522182830-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Cell metabolism reprogramming to sustain energy production, while reducing oxygen and energy consuming processes is crucially important for the adaptation to hypoxia/ischemia. Adaptive metabolic rewiring is controlled by hypoxia-inducible factors (HIFs). Accumulating experimental evidence indicates that timely activation of HIF in brain-resident cells improves the outcome from acute ischemic stroke. However, the underlying molecular mechanisms are still incompletely understood. Thus, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38774001/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&amp;fc=20220923065203&amp;ff=20240522181909&amp;v=2.18.0.post9&#43;e462414">Artificial Intelligence Electrocardiography to Predict Atrial Fibrillation in Patients With Chronic Lymphocytic Leukemia</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-22</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38774001-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1rkszs2hvz2rhp33oibanfew6vk-lzjjwtd4gwmllk8b-wcceh-fc-20220923065203-ff-20240522181909-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: An AI-ECG algorithm, in conjunction with the Mayo CLL AF risk score, can predict the risk of AF in patients with newly diagnosed CLL. Additional studies are needed to determine the role of AI-ECG in predicting AF risk in CLL patients treated with a Bruton tyrosine kinase &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38774001/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&amp;fc=20220923065203&amp;ff=20240523183254&amp;v=2.18.0.post9&#43;e462414">Artificial Intelligence Electrocardiography to Predict Atrial Fibrillation in Patients With Chronic Lymphocytic Leukemia</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-22</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38774001-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1rkszs2hvz2rhp33oibanfew6vk-lzjjwtd4gwmllk8b-wcceh-fc-20220923065203-ff-20240523183254-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: An AI-ECG algorithm, in conjunction with the Mayo CLL AF risk score, can predict the risk of AF in patients with newly diagnosed CLL. Additional studies are needed to determine the role of AI-ECG in predicting AF risk in CLL patients treated with a Bruton tyrosine kinase &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38774157/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240522182830&amp;v=2.18.0.post9&#43;e462414">User-centered development of an mHealth app for cardiovascular prevention</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-22</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38774157-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240522182830-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: The present study demonstrates the user-centered development of a guideline-based mHealth app for CVD prevention. Beta-testing and a preliminary usability study were used to further improve the HerzFit app until its official &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38774451/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240522182628&amp;v=2.18.0.post9&#43;e462414">SOX11 is a novel binding partner and endogenous inhibitor of SAMHD1 ara-CTPase activity in mantle cell lymphoma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-22</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38774451-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240522182628-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    The sterile alpha motif and histidine-aspartate (HD) domain containing protein 1 (SAMHD1) is a deoxynucleoside triphosphate triphosphohydrolase with ara-CTPase activity that confers cytarabine (ara-C) resistance in several haematological malignancies. Targeting SAMHD1&rsquo;s ara-CTPase activity has recently been demonstrated to enhance ara-C efficacy in acute myeloid leukemia. Here, we identify the transcription factor SRY-related HMG-box containing protein 11 (SOX11) as a novel direct &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38774451/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240523183435&amp;v=2.18.0.post9&#43;e462414">SOX11 is a novel binding partner and endogenous inhibitor of SAMHD1 ara-CTPase activity in mantle cell lymphoma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-22</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38774451-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240523183435-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    The sterile alpha motif and histidine-aspartate (HD) domain containing protein 1 (SAMHD1) is a deoxynucleoside triphosphate triphosphohydrolase with ara-CTPase activity that confers cytarabine (ara-C) resistance in several haematological malignancies. Targeting SAMHD1&rsquo;s ara-CTPase activity has recently been demonstrated to enhance ara-C efficacy in acute myeloid leukemia. Here, we identify the transcription factor SRY-related HMG-box containing protein 11 (SOX11) as a novel direct &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38774655/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&amp;fc=20220923065203&amp;ff=20240522181909&amp;v=2.18.0.post9&#43;e462414">TowardÂ a more patient-centered drug development process in clinical trials for patients with myelodysplastic syndromes/neoplasms (MDS): Practical considerations from the International Consortium for MDS (icMDS)</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-22</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38774655-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1rkszs2hvz2rhp33oibanfew6vk-lzjjwtd4gwmllk8b-wcceh-fc-20220923065203-ff-20240522181909-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Notable treatment advances have been made in recent years for patients with myelodysplastic syndromes/neoplasms (MDS), and several new drugs are under development. For example, the emerging availability of oral MDS therapies holds the promise of improving patients' health-related quality of life (HRQoL). Within this rapidly evolving landscape, the inclusion of HRQoL and other patient-reported outcomes (PROs) is critical to inform the benefit/risk assessment of new therapies or to assess &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38774655/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&amp;fc=20220923065203&amp;ff=20240523183254&amp;v=2.18.0.post9&#43;e462414">TowardÂ a more patient-centered drug development process in clinical trials for patients with myelodysplastic syndromes/neoplasms (MDS): Practical considerations from the International Consortium for MDS (icMDS)</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-22</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38774655-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1rkszs2hvz2rhp33oibanfew6vk-lzjjwtd4gwmllk8b-wcceh-fc-20220923065203-ff-20240523183254-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Notable treatment advances have been made in recent years for patients with myelodysplastic syndromes/neoplasms (MDS), and several new drugs are under development. For example, the emerging availability of oral MDS therapies holds the promise of improving patients' health-related quality of life (HRQoL). Within this rapidly evolving landscape, the inclusion of HRQoL and other patient-reported outcomes (PROs) is critical to inform the benefit/risk assessment of new therapies or to assess &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38774985/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240522182830&amp;v=2.18.0.post9&#43;e462414">Assessment of fluence- and dose-averaged linear energy transfer with passive luminescence detectors in clinical proton beams</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-22</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38774985-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240522182830-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    OBJECTIVE: This work investigates the use of passive luminescence detectors to determine different types of averaged linear energy transfer (\overline{LET}) for the energies relevant to proton therapy. The experimental results are compared to reference values obtained from Monte Carlo &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38775175/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240522182830&amp;v=2.18.0.post9&#43;e462414">Chronic hepatitis E masquerading as allograft rejection in a liver transplant recipient</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-22</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38775175-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240522182830-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38775392/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240522182830&amp;v=2.18.0.post9&#43;e462414">Prompts, Pearls, Imperfections: Comparing ChatGPT and a Human Researcher in Qualitative Data Analysis</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-22</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38775392-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240522182830-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The impact of ChatGPT and other large language model-based applications on scientific work is being debated across contexts and disciplines. However, despite ChatGPT&rsquo;s inherent focus on language generation and processing, insights regarding its potential for supporting qualitative research and analysis remain limited. In this article, we advocate for an open discourse on chances and pitfalls of AI-supported qualitative analysis by exploring ChatGPT&rsquo;s performance when analyzing an &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38775437/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240522182830&amp;v=2.18.0.post9&#43;e462414">The Global Reading Room: Imaging in Monoclonal Gammopathy of Undetermined Significance</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-22</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38775437-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240522182830-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38775487/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240522182830&amp;v=2.18.0.post9&#43;e462414">Invited Perspective: Toward Resilience-Community-Based Approaches to Managing Combined Sewer Overflows in a Changing Climate</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-22</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38775487-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240522182830-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38775664/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240522182830&amp;v=2.18.0.post9&#43;e462414">Resident and recruited macrophages differentially contribute to cardiac healing after myocardial ischemia</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-22</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38775664-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240522182830-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Cardiac macrophages are heterogenous in phenotype and functions, which has been associated with differences in their ontogeny. Despite extensive research, our understanding of the precise role of different subsets of macrophages in ischemia/reperfusion (I/R) injury remains incomplete. We here investigated macrophage lineages and ablated tissue macrophages in homeostasis and after I/R injury in a CSF1R-dependent manner. Genomic deletion of a fms-intronic regulatory element (FIRE) in the &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38775988/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240522182830&amp;v=2.18.0.post9&#43;e462414">Ophthalmological research in Germany: evaluation by an international expert panel</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-22</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38775988-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240522182830-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: The ophthalmological research performance in Germany was rated to be very good by an international expert panel. Nonetheless significant improvements were requested in the fields of translation (clinical trials, IP), synergy between specialized institutions and governmental funding for a German center for eye &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38776489/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240523183435&amp;v=2.18.0.post9&#43;e462414">Rapid Tumor DNA Analysis of Cerebrospinal Fluid Accelerates Treatment of Central Nervous System Lymphoma</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-22</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38776489-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240523183435-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    Delays and risks associated with neurosurgical biopsies preclude timely diagnosis and treatment of central nervous system (CNS) lymphoma and other CNS neoplasms. We prospectively integrated targeted rapid genotyping of cerebrospinal fluid (CSF) into the evaluation of 70 patients with CNS lesions of unknown etiology. Participants underwent genotyping of CSF-derived DNA using a qPCR-based approach for parallel detection of single-nucleotide variants in the MYD88, TERT promoter, IDH1, IDH2, &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38776510/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240523183435&amp;v=2.18.0.post9&#43;e462414">Targeting the tumor microenvironment for treating double refractory chronic lymphocytic leukemia</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-22</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38776510-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240523183435-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    The introduction of BTK inhibitors and BCL2 antagonists to the treatment of chronic lymphocytic leukemia has revolutionized therapy and improved patient outcomes. These agents have replaced chemoimmunotherapy as standard of care. Despite this progress, a new group of patients is currently emerging, which has become refractory or intolerant to both classes of agents, creating an unmet medical need. Here, we propose that the targeted modulation of the tumor microenvironment provides &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38776511/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=journals&amp;utm_content=7603509&amp;fc=None&amp;ff=20240523183435&amp;v=2.18.0.post9&#43;e462414">CD8&#43; T-cell Differentiation and Dysfunction Inform Treatment Response in Acute Myeloid Leukemia</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-22</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38776511-utm-source-curl-utm-medium-rss-utm-campaign-journals-utm-content-7603509-fc-none-ff-20240523183435-v-2-18-0-post9-e462414/">
    
    
    
    
    
      
    
    The interplay between T-cell states of differentiation, dysfunction, and treatment response in acute myeloid leukemia (AML) remains unclear. Here, we leveraged a multimodal approach encompassing high-dimensional flow cytometry and single-cell transcriptomics and found that early memory CD8+ T cells are associated with therapy response and exhibit a bifurcation into two distinct terminal end states. One state is enriched for markers of activation, whereas the other expresses NK-like &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38776928/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240523183437&amp;v=2.18.0.post9&#43;e462414">Are There Patient-Relevant Differences in the Material Properties of Intraocular Lenses?</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-22</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38776928-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240523183437-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38777342/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240523183437&amp;v=2.18.0.post9&#43;e462414">How do behavioral public policy experts see the role of complex systems perspectives? An expert interview study</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-22</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38777342-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240523183437-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Amidst the global momentum of behavioral insights (BI), there has been a shift from mostly nudge-based BI applications to systemic approaches. This is particularly pressing in public health, where interacting issues regularly produce unanticipated consequences. Regardless, little is known about adopting complex systems approaches in behavioral public policy. This study aims to capture current practices of international BI experts on the definition, application, drivers, and hindering factors &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38777431/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240523183437&amp;v=2.18.0.post9&#43;e462414">Motivational Interviewing improves postoperative nutrition goals within the Enhanced Recovery after Surgery (ERASÂ®) pathway in elective bowel surgery - A randomized clinical pilot trial</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-22</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38777431-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240523183437-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: MI may contribute to improve compliance with nutritional goals in the certified ERASÂ® protocol by increasing protein and calorie intake. The findings suggest further investigation of MI to help patients achieve their perioperative nutrition goals in different clinical &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38777929/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240523183437&amp;v=2.18.0.post9&#43;e462414">Turn Your Vision into Reality-AI-Powered Pre-operative Outcome Simulation in Rhinoplasty Surgery</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-22</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38777929-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240523183437-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSION: We presented a GAN-based simulator for rhinoplasty outcomes which used pre-operative patient images to predict accurate representations that were not perceived as different from real postoperative &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38778003/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1x5bM_TNL8gjogAcnslpo2s2PbDe-61JVM2h9yowOYSiZ7Dkrt&amp;fc=20220919211934&amp;ff=20240523183359&amp;v=2.18.0.post9&#43;e462414">CVGAE: A Self-Supervised Generative Method for Gene Regulatory Network Inference Using Single-Cell RNA Sequencing Data</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-22</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38778003-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1x5bm-tnl8gjogacnslpo2s2pbde-61jvm2h9yowoysiz7dkrt-fc-20220919211934-ff-20240523183359-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Gene regulatory network (GRN) inference based on single-cell RNA sequencing data (scRNAseq) plays a crucial role in understanding the regulatory mechanisms between genes. Various computational methods have been employed for GRN inference, but their performance in terms of network accuracy and model generalization is not satisfactory, and their poor performance is caused by high-dimensional data and network sparsity. In this paper, we propose a self-supervised method for gene regulatory &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38778031/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240523183437&amp;v=2.18.0.post9&#43;e462414">Climate Change and Mental Health: Position Paper of the European Psychiatric Association</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-22</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38778031-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240523183437-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38778045/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240523183437&amp;v=2.18.0.post9&#43;e462414">Higher habitual intakes of flavonoids and flavonoid-rich foods are associated with a lower incidence of type 2 diabetes in the UK Biobank cohort</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-22</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38778045-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240523183437-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    CONCLUSIONS: A higher consumption of flavonoid-rich foods was associated with lower T2D risk, potentially mediated by benefits to obesity/sugar metabolism, inflammation, kidney and liver function. Achievable increases in intakes of specific flavonoid-rich foods have the potential to reduce T2D &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38778080/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240523183437&amp;v=2.18.0.post9&#43;e462414">Comparison of the ABC and ACMG systems for variant classification</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-22</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38778080-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240523183437-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    The ABC and ACMG variant classification systems were compared by asking mainly European clinical laboratories to classify variants in 10 challenging cases using both systems, and to state if the variant in question would be reported as a relevant result or not as a measure of clinical utility. In contrast to the ABC system, the ACMG system was not made to guide variant reporting but to determine the likelihood of pathogenicity. Nevertheless, this comparison is justified since the ACMG &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38778110/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240523183437&amp;v=2.18.0.post9&#43;e462414">Life-cycle-coupled evolution of mitosis in close relatives of animals</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-22</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38778110-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240523183437-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Eukaryotes have evolved towards one of two extremes along a spectrum of strategies for remodelling the nuclear envelope during cell division: disassembling the nuclear envelope in an open mitosis or constructing an intranuclear spindle in a closed mitosis^(1,2). Both classes of mitotic remodelling involve key differences in the core division machinery but the evolutionary reasons for adopting a specific mechanism are unclear. Here we use an integrated comparative genomics and &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38778130/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&amp;fc=20220326224207&amp;ff=20240523183437&amp;v=2.18.0.post9&#43;e462414">Author Correction: mTOR regulates MAPKAPK2 translation to control the senescence-associated secretory phenotype</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-22</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38778130-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1faks-2qokct8hsmoqp1bcrq4yzyumyomxmf0molsq3dfb1e9v-fc-20220326224207-ff-20240523183437-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    No &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://pubmed.ncbi.nlm.nih.gov/38778427/?utm_source=curl&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1Rkszs2HVZ2RHP33OibaNFew6VK-LzjJWTD4GwmLlk8B-wCceh&amp;fc=20220923065203&amp;ff=20240523183254&amp;v=2.18.0.post9&#43;e462414">Three-dimensional chromatin landscapes in MLLr AML</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-22</span>
  </div>
  <div class="summary">
    <a href="/post/pubmed-ncbi-nlm-nih-gov-38778427-utm-source-curl-utm-medium-rss-utm-campaign-pubmed-2-utm-content-1rkszs2hvz2rhp33oibanfew6vk-lzjjwtd4gwmllk8b-wcceh-fc-20220923065203-ff-20240523183254-v-2-18-0-post9-/">
    
    
    
    
    
      
    
    Rearrangements of the mixed lineage leukemia (MLLr) gene are frequently associated with aggressive acute myeloid leukemia (AML). However, the treatment options are limited due to the genomic complexity and dynamics of 3D structure, which regulate oncogene transcription and leukemia development. Here, we carried out an integrative analysis of 3D genome structure, chromatin accessibility, and gene expression in gene-edited MLL-AF9 AML samples. Our data revealed profound MLLr-specific &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1444865141/Ofr4Lqrvr">å»å¹´æ²¡å»è¿çå°æ¹ï¼ä»å¹´è¡¥å¨ã - è½¬å @åéå¤©å·:&amp;ensp;@é©¬ä¼¯åº¸ èå¸ç­¾å®è¡ç¨ææ°åºçï¼è¿æ¬¡ï¼é©¬ä¼¯åº¸èå¸å¸¦çæ°ä¹¦ã#é£åä¹å¾#ã æ¥å°äºéåºååè¥ï¼é²éçå¨æ«...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-22</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1444865141-ofr4lqrvr/">
    
    
    
    
    
      
    
    å»å¹´æ²¡å»è¿çå°æ¹ï¼ä»å¹´è¡¥å¨ã<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å <!-- raw HTML omitted -->@åéå¤©å·<!-- raw HTML omitted -->:â<!-- raw HTML omitted -->@é©¬ä¼¯åº¸<!-- raw HTML omitted --> èå¸ç­¾å®è¡ç¨ææ°åºçï¼<!-- raw HTML omitted --><!-- raw HTML omitted -->è¿æ¬¡ï¼é©¬ä¼¯åº¸èå¸å¸¦çæ°ä¹¦ã<!-- raw HTML omitted --><!-- raw HTML omitted -->#é£åä¹å¾#<!-- raw HTML omitted --><!-- raw HTML omitted -->ã æ¥å°äºéåºååè¥ï¼é²éçå¨æ«ä¸èµ·æ¥èèç¾é£ä¸åå²é£ç¹äºå§ã<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img alt=&quot;[éè±è±]&quot; src=&ldquo;<a href="https://face.t.si">https://face.t.si</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OfvUijomD">ð»æè¿å¡æ¡æå¨å¶å®ç½åå¸äºç¸å½å¤çå»ä»¥åçè§é¢ãð»ä»¥åä¼¼ä¹å¹¶æ²¡æä»è¿ä¹å¤è¢«çå»çæåºæ¡ä¾ä¸­å¸åä»»ä½æè®­ï¼çè³è¿æå·ä¹ä¸ç»äºâ¦â¦ð»è¿ä¸ªè§é¢åçå¨ä»¥...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-22</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ofvuijomd/">
    
    
    
    
    
      
    
    ð»æè¿å¡æ¡æå¨å¶å®ç½åå¸äºç¸å½å¤çå»ä»¥åçè§é¢ã<!-- raw HTML omitted -->ð»ä»¥åä¼¼ä¹å¹¶æ²¡æä»è¿ä¹å¤è¢«çå»çæåºæ¡ä¾ä¸­å¸åä»»ä½æè®­ï¼çè³è¿æå·ä¹ä¸ç»äºâ¦â¦<!-- raw HTML omitted -->ð»è¿ä¸ªè§é¢åçå¨ä»¥åè®¡åæ°¸ä¹å é¢å¹¶åå²å æ²ååç Netzarim èµ°å»éï¼çè¿ä¸ªè¡¨ç°ï¼æ­£å¸¸äººé½ä¸ä¼è®¤ä¸ºä»¥åæè½åé¿æå®ä½è¿ä¸ªèµ°å»ã <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->åå®¹ä¸ç©ææ²³æ°´çå¾®åè§é¢<!-- raw HTML omitted --><!-- raw HTML omitted --> <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;video controls=&ldquo;controls&rdquo; poster=&ldquo;<a href="https://tvax2.s">https://tvax2.s</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OfvY27amr">ð»å¯¹ä¸èµ·ï¼ä½æ¯ï¼ï¼ï¼ï¼ï¼ [å¾ç][å¾ç][å¾ç][å¾ç][å¾ç]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-22</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ofvy27amr/">
    
    
    
    
    
      
    
    ð»å¯¹ä¸èµ·ï¼ä½æ¯ï¼ï¼ï¼ï¼ï¼ <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax1.sinaimg.cn/large/639b1bfbly1hpypz7mcqdj214l">https://tvax1.sinaimg.cn/large/639b1bfbly1hpypz7mcqdj214l</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OfvYVoGal">ð»âå½å°è­¦æ¹å å¥äºé¿æ ¹å»·ç±³è¥¿å¥¥åæ¯ççåç´§ç¼©æè®®ï¼é¿æ ¹å»·å°æ¹å®åä»¬ç°å¨æ­£å¨ç½¢å·¥ï¼ç±³è±çèªç±ä¸»ä¹æ¿åºä¸å¾ä¸ä»é¦é½æ´¾é£èé¦ç¹å·¥è¯å¾ç»´æç§©åºãâð»[åå¦A...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-22</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ofvyvogal/">
    
    
    
    
    
      
    
    ð»âå½å°è­¦æ¹å å¥äºé¿æ ¹å»·ç±³è¥¿å¥¥åæ¯ççåç´§ç¼©æè®®ï¼é¿æ ¹å»·å°æ¹å®åä»¬ç°å¨æ­£å¨ç½¢å·¥ï¼ç±³è±çèªç±ä¸»ä¹æ¿åºä¸å¾ä¸ä»é¦é½æ´¾é£èé¦ç¹å·¥è¯å¾ç»´æç§©åºãâ<!-- raw HTML omitted -->ð»<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ð»è¿ä»ä¹å§æ¬ï¼æèªæï¼<!-- raw HTML omitted -->ð»via redstreamnet æ°é»ç½ <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://h5.sinaimg.cn/upload/2015/09/25/3/timeline_card_small_video_default.png%22">https://h5.sinaimg.cn/upload/2015/09/25/3/timeline_card_small_video_default.png&quot;</a> referrerpolicy=&ldquo;no-referrer&rdquo; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Ofw2aaSbs">ð»ð©ðªå¾·å½æææ´ªå ¡å¤§å­¦çå­¦çå é¢äºç¤¾ä¼ç§å­¦ç³»å¤§æ¥¼ï¼æè®®ä»¥è²åå¨å æ²çç§æç­ç»ï¼ä»¥åå¾·å½çåè°ãð»æ´ªå ¡å¤§å­¦ä¹æ¯å¡å°Â·é©¬åæçæ¯æ ¡ãè¿æ¬¡è¡å¨æ¯æè¿...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-22</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ofw2aasbs/">
    
    
    
    
    
      
    
    ð»ð©ðªå¾·å½æææ´ªå ¡å¤§å­¦çå­¦çå é¢äºç¤¾ä¼ç§å­¦ç³»å¤§æ¥¼ï¼æè®®ä»¥è²åå¨å æ²çç§æç­ç»ï¼ä»¥åå¾·å½çåè°ã<!-- raw HTML omitted -->ð»æ´ªå ¡å¤§å­¦ä¹æ¯å¡å°Â·é©¬åæçæ¯æ ¡ãè¿æ¬¡è¡å¨æ¯æè¿å å¨ææçå¤§å­¦çä¸ºå£°æ´å·´åæ¯å¦èéåçä¸ç³»åè¡å¨ä¸­ææ°çä¸æ¬¡ã<!-- raw HTML omitted -->ð»äººç¾¤èéå¨æ´ªå ¡å¤§å­¦ç¤¾ä¼ç§å­¦ç³»å¤ï¼å£°æ´ç®åå æ®å¤§æ¥¼çå­¦çãå­¦çæè®®èå¨çªæ·ä¸æäºä¸æ¡æ¨ªå¹ï¼ä¸é¢åçâè´¾å·´å©äºå­¦é¢âã<!-- raw HTML omitted -->ð»ç°åºæå¤§éå¾·å½è­¦å¯å¨åºãä»ä»¬å°éäºå¤§æ¥¼çå¥å£ï¼å¹¶å³é­äºç ç©¶ææå¨çè¡éãæ´ªå ¡å¤§å­¦çæ ¡å­ä½äºææå¸ä¸­å¿ï¼æ¯ä¸ä¸ªæ¸¸å®¢ç»å¸¸åé¡¾çå°åºã<!-- raw HTML omitted -->ð»via redstreamnet æ°é»ç½<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;source src=&ldquo;<a href="https://f.video.weibocdn.com/o0/sHEGUSbplx08f3W9zDRm010">https://f.video.weibocdn.com/o0/sHEGUSbplx08f3W9zDRm010</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Ofw3P1VSB">ð»ð³ð´æªå¨å¤äº¤å¤§è£åæ¯å½­Â·å·´ç¹Â·è¾å¾·ï¼âå¦æå½éåäºæ³é¢æ­£å¼ç­¾åé®æä»¤ï¼é£ä¹åé©¬æ¯ç¸å³äººæåå¡å°¼äºè¡è®¿é®æªå¨ï¼æªå¨æä¹å¡é®æä»ä»¬ãâð»via quds...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-22</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ofw3p1vsb/">
    
    
    
    
    
      
    
    ð»ð³ð´æªå¨å¤äº¤å¤§è£åæ¯å½­Â·å·´ç¹Â·è¾å¾·ï¼âå¦æå½éåäºæ³é¢æ­£å¼ç­¾åé®æä»¤ï¼é£ä¹åé©¬æ¯ç¸å³äººæåå¡å°¼äºè¡è®¿é®æªå¨ï¼æªå¨æä¹å¡é®æä»ä»¬ãâ<!-- raw HTML omitted -->ð»via qudsnen æ°é»ç½<!-- raw HTML omitted -->ð»æå®ã <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Ofw4w3LpG">ð»æå®æ²¡å®ï¼ð»å«å¨æè¯è®ºåºåè°£è¨ãð»è¦åµæ¶çè¯èªå·±æ¾ä¸ªå°å»ã [å¾ç]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-22</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ofw4w3lpg/">
    
    
    
    
    
      
    
    ð»æå®æ²¡å®ï¼<!-- raw HTML omitted -->ð»å«å¨æè¯è®ºåºåè°£è¨ã<!-- raw HTML omitted -->ð»è¦åµæ¶çè¯èªå·±æ¾ä¸ªå°å»ã <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Ofwigxe4T">å¤è¯´ä¸å¥ï¼å¾å¤äººç¬å±±æèæ·å¤ä¸éè§éï¼ä½æ¯ï¼å¶å®ä¼ºåå¥½èªå·±çèææ¯æ·å¤ç¬¬ä¸è¦å¡åãå¥½éï¼æ ¹æ®å°å½¢çµæ´»éåºåéGTXï¼&#43;å¥½è¢å­ï¼ç¾æ¯ççå¥½ï¼è½ä¿æèé¨å¹²ç½ï¼...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-22</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ofwigxe4t/">
    
    
    
    
    
      
    
    å¤è¯´ä¸å¥ï¼å¾å¤äººç¬å±±æèæ·å¤ä¸éè§éï¼ä½æ¯ï¼å¶å®ä¼ºåå¥½èªå·±çèææ¯æ·å¤ç¬¬ä¸è¦å¡åãå¥½éï¼æ ¹æ®å°å½¢çµæ´»éåºåéGTXï¼+å¥½è¢å­ï¼ç¾æ¯ççå¥½ï¼è½ä¿æèé¨å¹²ç½ï¼å°è¥å°ï¼å¦ææ²¡æå¤ç¨çï¼ç­æ°´ç¶åå¡æè¢è½è®©ä½ å¾å¿«éæ°å¾å°å¹²ç½æ¸©æçéåè¢å­ã <!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&ldquo;width: 1rem;height: 1rem&rdquo; src=&ldquo;<a href="https://h5.sinaimg.cn/upload/2015/01/21/20/timeline_card_small_photo_default.png%22">https://h5.sinaimg.cn/upload/2015/01/21/20/timeline_card_small_photo_default.png&quot;</a> referrerpolicy=&ldquo;no-refer &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/OfwpDzfg1">ç­æ°´ç¶å¡éå­éï¼éå­å¡å¡æè¢éæå¥½ï¼æ°´æ±½å¾å¿«å°±ä¼åç»å¨å¡æè¢åå£ã//@å¯ä½ç¨å°ä¸æç¡®:ä¸æå°±é®ï¼å¡æè¢å¹²éå­çåçæ¯ä»ä¹ï¼ - è½¬å @åå®¹ä¸ç©ææ²³æ°´:&amp;ensp;...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-22</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ofwpdzfg1/">
    
    
    
    
    
      
    
    ç­æ°´ç¶å¡éå­éï¼éå­å¡å¡æè¢éæå¥½ï¼æ°´æ±½å¾å¿«å°±ä¼åç»å¨å¡æè¢åå£ã//<!-- raw HTML omitted -->@å¯ä½ç¨å°ä¸æç¡®<!-- raw HTML omitted -->:ä¸æå°±é®ï¼å¡æè¢å¹²éå­çåçæ¯ä»ä¹ï¼<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å <!-- raw HTML omitted -->@åå®¹ä¸ç©ææ²³æ°´<!-- raw HTML omitted -->:âð»ä½ä¸ºä¸ä½æ·å¤éæï¼æ·å¤æä¾ç¶æ¨èéå¹²å¸æ±å±+ä¿æ¸©å±+é²é£å±çä¸å ç©¿æ³ã<!-- raw HTML omitted -->ð»å¾å¤äººè¿äºè¿·ä¿¡âé²é£å±âï¼ä¹å°±æ¯æå¤é¢ä¸ä»¶ç¡¬å£³æ¯å¦å²éè¡£æèè½¯å£³çææï¼ï¼åèå¿½è§æéè¦çåå±åä¸­å±ã<!-- raw HTML omitted -->ð»ï¼æè§è¿ä¹°äºä»¶é¸BETAå°±ä»¥ä¸ºèªå·±æ æç»æä¸é¢æ£å¸è£å­éé¢å° &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Ofwreh2ks">ä»»ä½æåµä¸é½ä¸å»ºè®®ç´æ¥é è¿çå·ç¤éå­ï¼å®¹æè´¹éã//@å°é¬£ç_Little_Hyena:ä¸»è¦æ¯å½åé²è¥å¯¹äºç¨ç«è¿äºè°¨æï¼å½ç¶ï¼é²è¥ä¹è¦éµå®æ³å¾æ³è§ãä¸æ¦å®ç°ç¨ç«èªç±ï¼...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-22</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ofwreh2ks/">
    
    
    
    
    
      
    
    ä»»ä½æåµä¸é½ä¸å»ºè®®ç´æ¥é è¿çå·ç¤éå­ï¼å®¹æè´¹éã//<!-- raw HTML omitted -->@å°é¬£ç_Little_Hyena<!-- raw HTML omitted -->:ä¸»è¦æ¯å½åé²è¥å¯¹äºç¨ç«è¿äºè°¨æï¼å½ç¶ï¼é²è¥ä¹è¦éµå®æ³å¾æ³è§ãä¸æ¦å®ç°ç¨ç«èªç±ï¼å¾å¤äºæèªç¶è¿åèè§£ã//<!-- raw HTML omitted -->@åå®¹ä¸ç©ææ²³æ°´<!-- raw HTML omitted -->:ç­æ°´ç¶å¡éå­éï¼éå­å¡å¡æè¢éæå¥½ï¼æ°´æ±½å¾å¿«å°±ä¼åç»å¨å¡æè¢åå£ã<!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å &lt;a href=&ldquo;<a href="https://weibo.com/1671109627%22">https://weibo.com/1671109627&quot;</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/1671109627/Ofws2dmn0">ä»¥åï¼ææå¾å¤çè½¯å£³ãæç»ï¼åå¾å°çç¡¬å£³ï¼ä¹å°±æ¯å²éè¡£ï¼æç©¿çå°±è¡äºï¼ï¼æä¸å¤ªçè§£å¾å¤äººå¨åå¸ç¯å¢ä¹ç´è¿·å²éè¡£æ¯ä¸ºä»ä¹[è£å¼] - è½¬å @åå®¹ä¸ç©ææ²³æ°´:&amp;e...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-22</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-1671109627-ofws2dmn0/">
    
    
    
    
    
      
    
    ä»¥åï¼ææå¾å¤çè½¯å£³ãæç»ï¼åå¾å°çç¡¬å£³ï¼ä¹å°±æ¯å²éè¡£ï¼æç©¿çå°±è¡äºï¼ï¼æä¸å¤ªçè§£å¾å¤äººå¨åå¸ç¯å¢ä¹ç´è¿·å²éè¡£æ¯ä¸ºä»ä¹<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å <!-- raw HTML omitted -->@åå®¹ä¸ç©ææ²³æ°´<!-- raw HTML omitted -->:âð»ä½ä¸ºä¸ä½æ·å¤éæï¼æ·å¤æä¾ç¶æ¨èéå¹²å¸æ±å±+ä¿æ¸©å±+é²é£å±çä¸å ç©¿æ³ã<!-- raw HTML omitted -->ð»å¾å¤äººè¿äºè¿·ä¿¡âé²é£å±âï¼ä¹å°±æ¯ &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OfuAswhmT">ä¹ä¿å²ç»ªé[åå­]å¯ç±æ - è½¬å @Amerenka:&amp;ensp;å²©æ¬è²å #å²©æ¬è²å # 20240522 #ä»å¤©çè²å # ï¼1ï¼ï¼å¾1ï¼æ¯çæ æª¬ï¼2ï¼å½ç¶æ¯å¨Instagramä¸æ²¡æåè¿çè¯ï¼ä½è¯·...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-22</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-ofuaswhmt/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹ä¿å²ç»ªé<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img alt=&quot;[åå­]&quot; src=&ldquo;<a href="https://h5.sinaimg.cn/m/emoticon/icon/others/d_tuzi-d2b0222faa.png%22">https://h5.sinaimg.cn/m/emoticon/icon/others/d_tuzi-d2b0222faa.png&quot;</a> style=&ldquo;width:1em; height:1em;&rdquo; referrerpolicy=&ldquo;no-referrer&rdquo; &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OfuEpfLDf">ä¹ä¿å²ç»ªé[äº²äº²] - è½¬å @åäºèæ_åæ¥èµofficial:&amp;ensp;åäºå¶æ#åäºå¶æ# åäºèæinsãhazuki.p3.officialã åå äºåMrs. Green Appleåè¾ä¸èµ·çå±æ¼æ¼å±...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-22</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-ofuepfldf/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹ä¿å²ç»ªé<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> -  &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/OfvQVwfDK">ä¹ä¿å²ç»ªévia.ä¹æ¨å46 X&amp;NOGI46ann [å¾ç][å¾ç][å¾ç]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-22</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-ofvqvwfdk/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹ä¿å²ç»ªé<!-- raw HTML omitted --><!-- raw HTML omitted -->via.ä¹æ¨å46 X&amp;NOGI46ann <!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->&lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax2.sinaimg.cn/large/006z6n">https://tvax2.sinaimg.cn/large/006z6n</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://weibo.com/6015489225/Ofz8pa1WN">æ´æ°ä¸å¼  - è½¬å @é¡¶ç­TENä½¿:&amp;ensp;ä¹ä¿å²ç»ªévia.ä¹æ¨å46 X&amp;NOGI46ann [å¾ç][å¾ç][å¾ç]</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-22</span>
  </div>
  <div class="summary">
    <a href="/post/weibo-com-6015489225-ofz8pa1wn/">
    
    
    
    
    
      
    
    æ´æ°ä¸å¼ <!-- raw HTML omitted --><!-- raw HTML omitted --> - è½¬å <!-- raw HTML omitted -->@é¡¶ç­TENä½¿<!-- raw HTML omitted -->:â<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted -->ä¹ä¿å²ç»ªé<!-- raw HTML omitted --><!-- raw HTML omitted -->via.ä¹æ¨å46 X&amp;NOGI46ann &lt;img style=&quot;&quot; src=&ldquo;<a href="https://tvax1.sinaimg.cn/large/006z6nxLgy1hpypjn6uz4j31kw16oh41">https://tvax1.sinaimg.cn/large/006z6nxLgy1hpypjn6uz4j31kw16oh41</a> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.bilibili.com/video/BV1Tr421L7r5">éç¿å­ç¹åï¼æ²¡æä¸é¡¿é¥­æ¯æ è¾ç</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-22</span>
  </div>
  <div class="summary">
    <a href="/post/www-bilibili-com-video-bv1tr421l7r5/">
    
    
    
    
    
      
    
    è¸ç®å¤åï¼ååç®¡å¤<!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --><!-- raw HTML omitted --> &hellip;
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.zhihu.com/pin/1776539626817683456">å¼ æ¬ä¿¡åå¸äºæ³æ³: CPUçªç ´åæè¾¾å°mate40pçä½éªåï¼ &lt;br&gt; &lt;a href=&#34;https://www.zhihu.com/question/637361702/answer/3504139339&#34; data-insert-way=&#34;force&#34; d...</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-22</span>
  </div>
  <div class="summary">
    <a href="/post/www-zhihu-com-pin-1776539626817683456/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.zhihu.com/question/411663944/answer/3506153845">å¼ æ¬ä¿¡åç­äºé®é¢: excelå¦ä½æåæ°å­?</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-22</span>
  </div>
  <div class="summary">
    <a href="/post/www-zhihu-com-question-411663944-answer-3506153845/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.zhihu.com/question/445652533/answer/3506222499">å¼ æ¬ä¿¡åç­äºé®é¢: å¦ä½å¨pandas åå¼ä¸­æ¾åºè¿ç»­å¢å çè¡ï¼</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-22</span>
  </div>
  <div class="summary">
    <a href="/post/www-zhihu-com-question-445652533-answer-3506222499/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.zhihu.com/question/656336044/answer/3506138340">å¼ æ¬ä¿¡åç­äºé®é¢: excleæ ¹æ®æ¡ä»¶æåå¤ä¸ªå¼ï¼æ±å½æ°ï¼</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-22</span>
  </div>
  <div class="summary">
    <a href="/post/www-zhihu-com-question-656336044-answer-3506138340/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

<section class="article-list">
  <h1><a href="https://www.zhihu.com/question/656586657/answer/3506165958">å¼ æ¬ä¿¡åç­äºé®é¢: å¦ä½è®¡ç®åºEXCELè¡¨æ ¼ä¸­çæ¥æåè¡¨ä¸­ä¸ç³»ç»å½åæ¶é´å¨å¤§äº24å°æ¶çä¸ªæ°ï¼</a></h1>
  <div class="date-author">
    
    <span class="date">2024-05-22</span>
  </div>
  <div class="summary">
    <a href="/post/www-zhihu-com-question-656586657-answer-3506165958/">
    
    
    
    
    
      
    
    <!-- raw HTML omitted -->
    </a>
  </div>
</section>

</main>
</div>

<script async src="//yihui.name/js/center-img.js"></script>

<footer>

<div class="footer">
  <ul class="menu">
    
    <li><a href="/"><span data-hover="Home">Home</span></a></li>
    
    <li><a href="/about/"><span data-hover="About">About</span></a></li>
    
    <li><a href="/archives/"><span data-hover="Archive">Archive</span></a></li>
    
    <li><a href="/contributor/"><span data-hover="Contributor">Contributor</span></a></li>
    
    <li><a href="/index.xml"><span data-hover="Subscribe">Subscribe</span></a></li>
    
  </ul>
  
  <div class="copyright">Â© <a href="https://rainoffallingstar.github.io">Fallingstar</a> 2023 | <a href="https://github.com/rainoffallingstar">Github</a></div>
  
</div>
</footer>







</body>
</html>

